In HNSCC tumours, p63 expression is positively correlated with that of HAS3 and CD44, and the expression of three tumour‐related CD44 variants is associated with HNSCC progression in clinical samples (Maula et al., 2003; Misra et al., 2011). Here, TP63 is linked to head and neck squamous cell carcinoma.